Metabolism of lipids and lipid proteins CKO vs K5Cre Reactome by Kevin J. Mills (9270966)

Subjects:

Ceramide biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis. by Kevin J. Mills (9270966)

Subjects:

UHPLC-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Uncropped raw western blot images. by Kevin J. Mills (9270966)

Subjects:

LC-IMS-CID-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Fatty acids, triacylglycerol and ketone body metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Phospholipid metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Cholesterol biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis. by Kevin J. Mills (9270966)

Subjects:

Ictogenic changes in input correlation and adaptation gains are associated with increased dynamical variability during baseline activity. by Scott Rich (9873638)

“…<b>B</b>: <i>U</i>_<i>e</i> and <i>U</i>_<i>i</i> Normalized SD during baseline activity (top) and SLE rate (bottom) in the default model compared to two non-ictogenic scenarios— decreased from 50.0 to 40.0 and decreased from 1.2 to .8. …”

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

Subjects:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

Subjects:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

Illustrative examples of our study. by Mustafa Tuşat (21094179)

Absolute and relative stroke DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

S8 File - by Martha R. Smith (20410184)

Subjects:

Study populations of included studies. by Martha R. Smith (20410184)

Subjects:

Future research directions. by Martha R. Smith (20410184)

Subjects: